Product Information
GLIMEPIRIDE 4 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0514 per EA under NDC 43547039610. Its NADAC has been published 482 times since May 31, 2017.
FDA first approved this application on Dec 23, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547039610
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GLIMEPIRIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077370FDA Approved
12/23/2005
TE Code
AB
On Market Since
1/30/2017
Pharmacological Classes
Price Statistics
The NADAC for GLIMEPIRIDE 4 MG TABLET has been published 482 times since May 31, 2017, and over the history we have for it it has declined 51.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0514 per EA |
|---|---|
| All-time high | $0.1215 (Jul 12, 2017) |
| All-time low | $0.0274 (May 22, 2024) |
| 52-week high | $0.0524 |
| 52-week low | $0.0375 |
| Median price | $0.0509 |
| Average price | $0.0555 |
| Largest weekly change | +73.8% (Jun 19, 2024) |
| Weeks tracked | 482 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLIMEPIRIDE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIMEPIRIDE 4 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0514 per EA (NDC 43547039610), effective Aug 19, 2026.
How has the price of GLIMEPIRIDE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIMEPIRIDE 4 MG TABLET has declined 51.0%. It has been tracked across 482 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for GLIMEPIRIDE 4 MG TABLET?
Since May 31, 2017, the NADAC for GLIMEPIRIDE 4 MG TABLET has ranged from a low of $0.0274 (May 22, 2024) to a high of $0.1215 (Jul 12, 2017), with a median of $0.0509 per EA.
Are there cheaper alternatives to GLIMEPIRIDE 4 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLIMEPIRIDE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GLIMEPIRIDE 4 MG TABLET?
GLIMEPIRIDE 4 MG TABLET (NDC 43547039610) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.